6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: March 4, 2025
Period of Report: March 4, 2025
Accession Number: 0001213900-25-019719

View Document ↗ View on SEC.gov ↗